This inventor holds 2 USPTO granted patents. Top assignee: Dongwha Pharm. Ind. Co., Ltd.. Active years: 1999.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1999
Title: Hee Soon Lee: Innovator in Antitumor Agents
Introduction
Hee Soon Lee is a notable inventor based in Daejeon, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antitumor agents. His innovative work has led to the filing of multiple patents, showcasing his commitment to advancing medical science.
Latest Patents
Hee Soon Lee holds 2 patents related to arylsulfonylimidazolone derivatives. His latest patents focus on a novel arylsulfonylimidazolone derivative that demonstrates superior antineoplastic activity compared to known sulfonylurea antitumor agents. This invention also exhibits minimal side effects, making it a promising candidate for further development in cancer treatment.
Career Highlights
Hee Soon Lee is currently associated with Dongwha Pharm. Ind. Co., Ltd., where he continues to innovate in the pharmaceutical industry. His work is characterized by a strong emphasis on research and development, particularly in creating effective treatments for cancer.
Collaborations
Hee Soon Lee collaborates with esteemed colleagues, including Sung June Yoon and Yong Ho Chung. These partnerships enhance the research environment and contribute to the successful development of new pharmaceutical solutions.
Conclusion
Hee Soon Lee's contributions to the field of antitumor agents highlight his role as a leading inventor in the pharmaceutical industry. His innovative patents and collaborations reflect his dedication to improving cancer treatment options.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile